These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 9024567)
1. Smith-Lemli-Opitz syndrome produced in rats with AY 9944 treated by intravenous injection of lipoprotein cholesterol. Chambers CM; McLean MP; Ness GC Am J Med Genet; 1997 Jan; 68(3):322-7. PubMed ID: 9024567 [TBL] [Abstract][Full Text] [Related]
2. Treatment of the cholesterol biosynthetic defect in Smith-Lemli-Opitz syndrome reproduced in rats by BM 15.766. Xu G; Salen G; Shefer S; Ness GC; Chen TS; Zhao Z; Salen L; Tint GS Gastroenterology; 1995 Oct; 109(4):1301-7. PubMed ID: 7557099 [TBL] [Abstract][Full Text] [Related]
3. Reproducing abnormal cholesterol biosynthesis as seen in the Smith-Lemli-Opitz syndrome by inhibiting the conversion of 7-dehydrocholesterol to cholesterol in rats. Xu G; Salen G; Shefer S; Ness GC; Chen TS; Zhao Z; Tint GS J Clin Invest; 1995 Jan; 95(1):76-81. PubMed ID: 7814648 [TBL] [Abstract][Full Text] [Related]
4. Changes in serum sterols of rats treated with 7-dehydrocholesterol-delta 7-reductase inhibitors: comparison to levels in humans with Smith-Lemli-Opitz syndrome. Wolf C; Chevy F; Pham J; Kolf-Clauw M; Citadelle D; Mulliez N; Roux C J Lipid Res; 1996 Jun; 37(6):1325-33. PubMed ID: 8808767 [TBL] [Abstract][Full Text] [Related]
5. Oxidized derivatives of 7-dehydrocholesterol induce growth retardation in cultured rat embryos: a model for antenatal growth retardation in the Smith-Lemli-Opitz syndrome. Gaoua W; Chevy F; Roux C; Wolf C J Lipid Res; 1999 Mar; 40(3):456-63. PubMed ID: 10064734 [TBL] [Abstract][Full Text] [Related]
6. Hepatic isoprenoid metabolism in a rat model of Smith-Lemli-Opitz Syndrome. Keller RK; Mitchell DA; Goulah CC; Fliesler SJ Lipids; 2013 Mar; 48(3):219-29. PubMed ID: 23361583 [TBL] [Abstract][Full Text] [Related]
7. Cholesterol deficit but not accumulation of aberrant sterols is the major cause of the teratogenic activity in the Smith-Lemli-Opitz syndrome animal model. Gaoua W; Wolf C; Chevy F; Ilien F; Roux C J Lipid Res; 2000 Apr; 41(4):637-46. PubMed ID: 10744785 [TBL] [Abstract][Full Text] [Related]
8. Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome. Salen G; Tint GS; Xu G; Batta AK; Irons M; Elias ER Ital J Gastroenterol; 1995 Dec; 27(9):506-8. PubMed ID: 8919321 [TBL] [Abstract][Full Text] [Related]
9. Abnormal cholesterol biosynthesis as in Smith-Lemli-Opitz syndrome disrupts normal skeletal development in the rat. Kolf-Clauw M; Chevy F; Ponsart C J Lab Clin Med; 1998 Mar; 131(3):222-7. PubMed ID: 9523845 [TBL] [Abstract][Full Text] [Related]
10. Abnormal cholesterol biosynthesis produced by AY 9944 in the rat leads to skeletal deformities similar to the Smith-Lemli-Opitz syndrome. Batta AK; Salen G J Lab Clin Med; 1998 Mar; 131(3):192-3. PubMed ID: 9523840 [No Abstract] [Full Text] [Related]
11. Inhibition of 7-dehydrocholesterol reductase by the teratogen AY9944: a rat model for Smith-Lemli-Opitz syndrome. Kolf-Clauw M; Chevy F; Wolf C; Siliart B; Citadelle D; Roux C Teratology; 1996 Sep; 54(3):115-25. PubMed ID: 8987154 [TBL] [Abstract][Full Text] [Related]
13. Role of cholesterol in embryonic development. Roux C; Wolf C; Mulliez N; Gaoua W; Cormier V; Chevy F; Citadelle D Am J Clin Nutr; 2000 May; 71(5 Suppl):1270S-9S. PubMed ID: 10799401 [TBL] [Abstract][Full Text] [Related]
14. [Inborn error of cholesterol biosynthesis: Smith-Lemli-Opitz syndrome]. Koczok K; V Oláh A; P Szabó G; Oláh É; Török O; Balogh I Orv Hetil; 2015 Oct; 156(42):1695-702. PubMed ID: 26551309 [TBL] [Abstract][Full Text] [Related]
15. Normal and inhibited cholesterol synthesis in the cultured rat embryo. Llirbat B; Wolf C; Chevy F; Citadelle D; Bereziat G; Roux C J Lipid Res; 1997 Jan; 38(1):22-34. PubMed ID: 9034197 [TBL] [Abstract][Full Text] [Related]
16. Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome. Salen G; Shefer S; Batta AK; Tint GS; Xu G; Honda A; Irons M; Elias ER J Lipid Res; 1996 Jun; 37(6):1169-80. PubMed ID: 8808751 [TBL] [Abstract][Full Text] [Related]
17. Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7alpha-hydroxylase and 27-hydroxylase activities in rat liver. Honda A; Salen G; Shefer S; Batta AK; Honda M; Xu G; Tint GS; Matsuzaki Y; Shoda J; Tanaka N J Lipid Res; 1999 Aug; 40(8):1520-8. PubMed ID: 10428990 [TBL] [Abstract][Full Text] [Related]
18. An efficient synthesis of 4α- and 4β-hydroxy- 7-dehydrocholesterol, biomarkers for patients with and animal models of the Smith-Lemli-Opitz syndrome. Kawamoto H; Ohmori Y; Maekawa M; Shimada M; Mano N; Iida T Chem Phys Lipids; 2013; 175-176():73-8. PubMed ID: 23920082 [TBL] [Abstract][Full Text] [Related]
19. Novel oxysterols observed in tissues and fluids of AY9944-treated rats: a model for Smith-Lemli-Opitz syndrome. Xu L; Liu W; Sheflin LG; Fliesler SJ; Porter NA J Lipid Res; 2011 Oct; 52(10):1810-20. PubMed ID: 21817059 [TBL] [Abstract][Full Text] [Related]